Bakrieland Development Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bakrieland Development Tbk. trades at Rp22 (market cap 1T, 28.75M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Bakrieland Development Tbk. is far larger — about 6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bakrieland Development Tbk. is more actively traded (28.75M versus 71K). Which is the better fit depends on your goals.
| ELTY | OBAT | |
|---|---|---|
Market Cap | 1T | 167.37B |
Volume | 28.75M | 71K |
Lot | 287.49K | 710 |
Turnover | 638.29M | 17.51M |
Average Price | 22.2 | 246.63 |
Value | 638.29M | 17.51M |
Indicative Equilibrium Price | 22 | 246 |
Indicative Equilibrium Volume | 65.62K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bakrieland Development Tbk. (“The Company”) was established with Notarial Deed No. 209 of John Leonard Waworuntu, S.H., dated June 12, 1990. The Company's articles of association have been amended several times, among others, the changes of the Company's name from PT Elang Realty (formerly PT. Purilestari Indah Pratama) Tbk. to PT Bakrieland Development Tbk. which have been notarized by Notarial Deed No. 29 of Harun Kamil, S.H., dated April 3, 1997.
Read more on ELTY →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →